Articles
CAR T cells v chemo for childhood leukaemia: are we ready for the next step?
Chimeric antigen receptor (CAR) T cells, genetically engineered immune cells targeted to attack cancers, are one of the most exciting breakthrough cancer treatments in oncology today. After decades of incremental development, its…